An adrenal incidentaloma is a lump in the adrenal gland that shows up by accident - usually during a CT or MRI scan done for something else, like a car accident, abdominal pain, or even a routine checkup. It’s not something you feel, and most people have no idea it’s there until a doctor points it out. These are surprisingly common. About 1 in 50 adults has one, and that number jumps to more than 1 in 14 for people over 70. The real question isn’t whether you have one - it’s whether it’s dangerous.

What Exactly Is an Adrenal Incidentaloma?

The adrenal glands sit on top of each kidney. They make hormones that control your blood pressure, stress response, metabolism, and even your sex drive. An incidentaloma is just a mass found by imaging that wasn’t being looked for. Most are small, under 2 cm, and harmless. But not all. About 80% are benign, non-functioning adenomas - basically, harmless lumps that don’t make extra hormones. The other 20%? That’s where things get tricky. About 5-10% of these masses produce too much hormone. A few percent are cancerous. And missing one of those can be life-threatening.

Why Evaluation Matters - Even If You Feel Fine

You might think, "If I feel fine, why worry?" But here’s the catch: adrenal tumors don’t always cause symptoms until they’re dangerous. A pheochromocytoma - a rare tumor that makes too much adrenaline - can cause sudden, deadly spikes in blood pressure during surgery if not caught first. A cortisol-producing tumor can slowly raise your blood sugar, weaken your bones, and increase your risk of heart disease without you ever feeling sick. And adrenocortical carcinoma? It’s rare - only about 2% of incidentalomas - but it grows fast and spreads if not removed early.

That’s why every adrenal incidentaloma gets evaluated the same way: hormone tests first, then imaging. No exceptions.

The Three-Step Evaluation Process

The current standard - backed by the Endocrine Society and major medical centers - is a clear, step-by-step approach.

1. Check for hormone overproduction. Every single case needs three tests: one for adrenaline-type hormones (metanephrines), one for cortisol, and one for aldosterone if you have high blood pressure or low potassium.
2. Look at the scan. The first scan is usually an unenhanced CT. If the tumor has a density under 10 Hounsfield units, it’s almost certainly a benign adenoma - about 75% of the time. If it’s over 10, or if it looks irregular, has uneven texture, or is larger than 4 cm, you need more imaging - often an MRI or a specialized CT with contrast.
3. Measure growth. If the mass is indeterminate, you get a repeat scan in 6 to 12 months. If it grows more than 1 cm in a year, or doubles in volume, that’s a red flag.

These aren’t suggestions - they’re the minimum required steps. Skipping any one of them increases risk.

When Surgery Is Necessary

Not every adrenal mass needs to come out. But some absolutely do. Here’s when surgery is recommended:

• Any tumor that makes hormones. That includes pheochromocytomas (adrenaline), cortisol-producing tumors (Cushing’s), or aldosterone-producing adenomas (Conn’s syndrome). Size doesn’t matter. If it’s making too much hormone, remove it.
• Tumors larger than 4 cm. The risk of cancer jumps sharply here. Tumors under 4 cm have less than a 1% chance of being cancer. At 4-6 cm, it’s about 5%. Over 6 cm? That’s a 25% risk. That’s why 4 cm is the cutoff for surgical consideration.
• Tumors with suspicious imaging. If the CT shows irregular edges, uneven texture, or signs of spreading to nearby tissue, surgery is the next step - even if the tumor is small.
• Rapid growth. If a mass grows more than 1 cm in a year, it’s treated like cancer until proven otherwise.

For pheochromocytomas, surgery isn’t just about removal - it’s about preparation. You need to be on alpha-blockers for at least 7 to 14 days before surgery. Skipping this step can cause a hypertensive crisis during anesthesia - which can be fatal.

What About Small, Non-Functioning Tumors?

If your tumor is under 4 cm, doesn’t make hormones, and looks smooth and even on the scan - you’re probably fine. No surgery. No follow-up scans. No medication. Just live your life. That’s what the guidelines say. Yet many patients and even some doctors get anxious and want to repeat scans every year. That’s unnecessary. It adds cost, radiation exposure, and stress - with zero benefit.

Only about 10-15% of cases are truly indeterminate. Those are the ones that need a repeat scan in 6-12 months. After that, if nothing changes, you’re done.

The Hidden Challenge: Subclinical Cushing’s

One of the hardest parts of managing adrenal incidentalomas is spotting subclinical Cushing’s syndrome - when the tumor makes just a little too much cortisol. You don’t have the classic symptoms like moon face or purple stretch marks. But you still have higher blood pressure, more belly fat, worse insulin resistance, and higher risk of heart attacks and strokes. Studies show these patients have worse long-term outcomes than those with normal hormone levels.

The standard test is the 1 mg dexamethasone suppression test. If your cortisol is above 1.8 μg/dL after the pill, it’s suspicious. New research from 2023 shows that testing urine for steroid metabolites - not just cortisol - is even more accurate. It catches 92% of cases, compared to 80% with the old test. This new method is starting to show up in top centers, but it’s not yet routine everywhere.

Who Should You See?

This isn’t a general practitioner issue. It’s a specialist problem. You need an endocrinologist who knows adrenal tumors, a radiologist who’s read hundreds of adrenal scans, and ideally, a surgeon who does adrenal operations regularly. Studies show patients treated at specialized adrenal centers are 92% satisfied with their care - compared to 68% at general hospitals.

The problem? Only 37 hospitals in the U.S. are officially designated as Comprehensive Adrenal Centers. Many community labs can’t even run the metanephrine test. In fact, only 45% of community hospitals have immediate access to it. That means delays, misdiagnoses, and missed diagnoses.

What’s Changing in 2026?

The Endocrine Society is updating its guidelines this year. The big shift? They’re moving toward more aggressive treatment for subclinical Cushing’s. If your post-dexamethasone cortisol is above 5.0 μg/dL - not just 1.8 - surgery is now strongly recommended. Why? Because new long-term data shows these patients have significantly better blood sugar control, lower blood pressure, and fewer heart events after removal.

Also, the 1 cm cutoff for calling something an incidentaloma is being questioned. Japan uses 2 cm. Some experts say smaller masses are rarely dangerous. But European and U.S. guidelines still hold at 1 cm. Until there’s consensus, err on the side of caution.

What Patients Say

Online forums are full of stories from people waiting for test results. One Reddit user wrote: "I went from feeling fine to terrified that I had cancer. I couldn’t sleep. The waiting was worse than the diagnosis." A survey of 142 patients found 78% felt extreme anxiety during the evaluation process. That’s real. And it’s why clear communication matters.

But those who got care at specialized centers report something different: "They explained everything. Told me what I needed to know - and what I didn’t. I felt in control." That’s the goal: clarity, not fear.

Final Takeaway

Adrenal incidentalomas are common. Most are harmless. But a few can kill you if ignored. The key is not to panic - but to act. Get the right tests. Know the thresholds. See the right specialists. And don’t let fear lead to unnecessary scans or surgery. The system isn’t perfect - but if you follow the evidence, you’ll avoid the biggest risks.